摘要
目的研究超声分子成像在乳腺病灶良恶性质鉴别诊断中的应用效果。方法选取2019年1月至2020年6月前往本院诊治的120例乳腺疾病患者临床资料,以病理结果为参照,对比超声分子成像、乳腺钼靶检查、超声检查鉴别诊断结果差异。结果120例乳腺疾病患者病理结果中良性80例、恶性40例,符合率相比较,超声分子成像(95.83%)>乳腺钼靶(85.00%)>超声检查(73.33%),差异有统计学意义(P<0.05);超声分子成像提示:乳腺恶性病灶在造影剂注入后呈高增强,而乳腺良性病灶在造影剂注入后无增强;以病理结果为参照,敏感度、特异度、准确度相比较,超声分子成像(96.25%、95.00%、95.83%)>乳腺钼靶(86.25%、82.50%、85.00%)>超声检查(77.50%、65.00%、73.33%),差异有统计学意义(P<0.05)。结论在乳腺病灶良恶性质鉴别诊断中超声分子成像取得的应用效果显著优于乳腺钼靶检查以及超声检查,值得在今后诊断工作中推广使用。
Objective To study the application effect of ultrasound molecular imaging in the differential diagnosis of benign and malignant breast lesions.Methods The clinical data of 120 breast disease patients who visited our hospital from January 2019 to June 2020 were retrospectively analyzed.Based on the pathological results,the differences in the differential diagnosis results of ultrasound molecular imaging,mammography,and ultrasound were compared.Results The pathological results of 120 patients with breast disease included 80 benign and 40 malignant.Compared with the coincidence rate,molecular ultrasound imaging(95.83%)>mammography(85.00%)>ultrasound(73.33%),the difference was statistically significant(P<0.05);Ultrasound molecular imaging suggested that malignant breast lesions showed high enhancement after contrast agent injection,while benign breast lesions showed no enhancement after contrast agent injection;based on case results,sensitivity,specificity,and accuracy were comparable In comparison,ultrasound molecular imaging(96.25%,95.00%,95.83%)>mammography(86.25%,82.50%,85.00%)>ultrasound(77.50%,65.00%,73.33%),the difference was statistically significant(P<0.05).Conclusion The application effect of molecular ultrasound imaging in the differential diagnosis of benign and malignant breast lesions is significantly better than that of mammography and ultrasound,and it is worthy of promotion and use in future diagnosis.
作者
田苗
高小瞻
马飞
王露
TIAN Miao;GAO Xiaozhan;MA Fei;WANG Lu(Ultrasound Department,Second People's Hospital of Three Gorges University(Yichang Second People's Hospital),Yichang,Hubei,China,443000)
出处
《分子诊断与治疗杂志》
2021年第10期1623-1626,共4页
Journal of Molecular Diagnostics and Therapy
基金
湖北陈孝平科技发展基金科技计划项目(2020-036)。
关键词
乳腺病灶
良恶性质
鉴别诊断
超声分子成像
Breast Lesions
Benign and Malignant
Differential Diagnosis
Ultrasound Molecular Imaging
